# A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022

> **NCT01254656** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 108 (actual)

## Conditions studied

- HIV-1

## Interventions

- **DRUG:** lersivirine
- **DRUG:** lersivirine
- **DRUG:** efavirenz
- **DRUG:** lersivirine
- **DRUG:** lersivirine
- **DRUG:** etravirine

## Key facts

- **NCT ID:** NCT01254656
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-02
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 108 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2014-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01254656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01254656, "A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01254656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*